Bosaeed, Mohammad http://orcid.org/0000-0003-2971-5141
Mahmoud, Ebrahim
Hussein, Mohammad
Alharbi, Ahmad
Alsaedy, Abdulrahman
Alothman, Adel
Aljeraisy, Majed
Alqahtani, Hajar
Nashabat, Marwan
Almutairi, Badriah
Almaghaslah, Manar
Aldibasi, Omar
AlJohani, Sameera
Bouchama, Abderrezak
Arabi, Yaseen
Alaskar, Ahmad
Funding for this research was provided by:
King Abdullah International Medical Research Center
Article History
Received: 14 October 2020
Accepted: 16 October 2020
First Online: 31 October 2020
Ethics approval and consent to participate
: This protocol was approved by the IRB in the Ministry of National Guard Health Affairs (MNGHA) and Saudi FDA with Protocol No RC20/174/R. The authors certify that this trial has received ethical approval from the appropriate ethical committee as described above.Before inclusion in the study, conscious patients will be informed of the purpose and clinical procedures required by the protocol. The investigators in each center will explain the purpose, risks, and benefits associated with study participation. Also, patients will be informed of their right to withdraw from the study at any time without explanation and without losing the right to future medical care. Patients will be informed of the purpose and clinical procedures required by the protocol prior to providing their consent for participation in this study
: Not applicable.
: The authors declare that they have no competing interests